Brexit. Consequences for API manufacturers

This article explores the consequences for companies manufacturing active pharmaceutical ingredients (APIs) which export and import to the European Union and whose plants are located in the United Kingdom or have a relationship with the country. It outlines and lists the different sectors affected by Brexit and the existing solutions for those countries not members of the European Union.

Source link